Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and… Read more
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.010x
Based on the latest financial reports, Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a cash flow conversion efficiency ratio of -0.010x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-64.53 Million) by net assets (€6.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Zhong Xin Pharmaceutical Group Corporation Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SHG:600063
|
0.159x |
|
Auren Energia S.A.
SA:AURE3
|
0.012x |
|
Beijing Lanxum Tech Co
SHE:300010
|
-0.070x |
|
Isiklar Enerji ve Yapi Holding AS
IS:IEYHO
|
-0.116x |
|
Farasis Energy Gan Zhou Co Ltd
SHG:688567
|
0.036x |
|
ProPetro Holding Corp
NYSE:PUMP
|
0.050x |
|
WALLENSTAM AB SER.B
F:WAE
|
N/A |
|
Hangzhou Robam Appliances Co Ltd
SHE:002508
|
0.023x |
Annual Cash Flow Conversion Efficiency for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Zhong Xin Pharmaceutical Group Corporation Limited from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €7.85 Billion | €924.67 Million | 0.118x | +13.69% |
| 2023-12-31 | €6.65 Billion | €688.49 Million | 0.104x | +0.23% |
| 2022-12-31 | €6.55 Billion | €677.25 Million | 0.103x | -21.01% |
| 2021-12-31 | €6.51 Billion | €852.40 Million | 0.131x | +15.96% |
| 2020-12-31 | €5.95 Billion | €671.42 Million | 0.113x | +25.79% |
| 2019-12-31 | €5.52 Billion | €495.49 Million | 0.090x | +29.50% |
| 2018-12-31 | €5.05 Billion | €350.14 Million | 0.069x | +8165.98% |
| 2017-12-31 | €4.63 Billion | €-3.97 Million | -0.001x | -100.88% |
| 2016-12-31 | €4.30 Billion | €417.77 Million | 0.097x | +10.55% |
| 2015-12-31 | €4.11 Billion | €360.58 Million | 0.088x | -9.77% |
| 2014-12-31 | €2.95 Billion | €286.85 Million | 0.097x | +17.45% |
| 2013-12-31 | €2.57 Billion | €213.44 Million | 0.083x | -- |